94 related articles for article (PubMed ID: 29656866)
1. Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2018 Jun; 96():131-132. PubMed ID: 29656866
[No Abstract] [Full Text] [Related]
2. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658
[TBL] [Abstract][Full Text] [Related]
3. Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes.
Saghatchian M; Mook S; Pruneri G; Viale G; Glas AM; Guerin S; Cardoso F; Piccart M; Tursz T; Delaloge S; van't Veer L
Breast; 2013 Oct; 22(5):682-90. PubMed ID: 23347730
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
5. A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancer.
Groenendijk FH; Jager A; Cardoso F; van Deurzen CHM
Breast; 2018 Apr; 38():125-131. PubMed ID: 29310037
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.
Aalders KC; Kuijer A; Straver ME; Slaets L; Litiere S; Viale G; Van't Veer LJ; Glas AM; Delorenzi M; van Dalen T; Tryfonidis K; Piccart MJ; Cardoso F; Rutgers EJ;
Eur J Cancer; 2017 Jul; 79():98-105. PubMed ID: 28477490
[TBL] [Abstract][Full Text] [Related]
7. [Validation and clinical application of MammaPrint® in patients with breast cancer].
Cuadros M; Llanos A
Med Clin (Barc); 2011 May; 136(14):627-32. PubMed ID: 20416899
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
[TBL] [Abstract][Full Text] [Related]
9. Performance characteristics of the MammaPrint
Delahaye LJ; Wehkamp D; Floore AN; Bernards R; Van't Veer LJ; Glas AM
Per Med; 2013 Nov; 10(8):801-811. PubMed ID: 29776281
[TBL] [Abstract][Full Text] [Related]
10. [Gene expression classifiers in the prognosis of breast cancer].
Drukker CA; Schmidt MK; van Dalen T; van der Hoeven JJ; Linn SC; Rutgers EJ
Ned Tijdschr Geneeskd; 2014; 158():A7001. PubMed ID: 24780571
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of the 70-gene MammaPrint profile in a Japanese population.
Ishitobi M; Goranova TE; Komoike Y; Motomura K; Koyama H; Glas AM; van Lienen E; Inaji H; Van't Veer LJ; Kato K
Jpn J Clin Oncol; 2010 Jun; 40(6):508-12. PubMed ID: 20110242
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116].
Puliti D; Bucchi L; Mancini S; Paci E; Baracco S; Campari C; Canuti D; Cirilli C; Collina N; Conti GM; Di Felice E; Falcini F; Michiara M; Negri R; Ravaioli A; Sassoli De' Bianchi P; Serafini M; Zorzi M; Caldarella A; Cataliotti L; Zappa M;
Eur J Cancer; 2017 Nov; 85():160. PubMed ID: 28870467
[No Abstract] [Full Text] [Related]
13. An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile?
Nicolini A; Ferrari P; Fallahi P; Antonelli A
Future Oncol; 2012 Feb; 8(2):131-4. PubMed ID: 22335577
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].
Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A
Eur J Cancer; 2016 Nov; 67():223. PubMed ID: 27680408
[No Abstract] [Full Text] [Related]
15. Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.
Seguí MÁ; Crespo C; Cortés J; Lluch A; Brosa M; Becerra V; Chiavenna SM; Gracia A
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):889-99. PubMed ID: 25213317
[TBL] [Abstract][Full Text] [Related]
16. [Validation and clinical application of MammaPrint
Sánchez-Forgach ER; Carpinteyro-Espín U; Alemán-Áviles JA; Sánchez-Basurto C
Cir Cir; 2017; 85(4):320-324. PubMed ID: 27979362
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.
Retèl VP; Joore MA; Knauer M; Linn SC; Hauptmann M; Harten WH
Eur J Cancer; 2010 May; 46(8):1382-91. PubMed ID: 20359886
[TBL] [Abstract][Full Text] [Related]
18. Impact of MammaPrint on Clinical Decision-Making in South African Patients with Early-Stage Breast Cancer.
Pohl H; Kotze MJ; Grant KA; van der Merwe L; Pienaar FM; Apffelstaedt JP; Myburgh EJ
Breast J; 2016 Jul; 22(4):442-6. PubMed ID: 27079770
[TBL] [Abstract][Full Text] [Related]
19. European inter-institutional impact study of MammaPrint.
Cusumano PG; Generali D; Ciruelos E; Manso L; Ghanem I; Lifrange E; Jerusalem G; Klaase J; de Snoo F; Stork-Sloots L; Dekker-Vroling L; Lutke Holzik M
Breast; 2014 Aug; 23(4):423-8. PubMed ID: 24685596
[TBL] [Abstract][Full Text] [Related]
20. Is gene array testing to be considered routine now?
Paik S
Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
